Author

David J. Rak

Observed name: David Rak

Institutions: Minnesota Pollution Control Agency, Minnesota Department of Health

Observed institutions: Minnesota Pollution Control Agency, Minnesota Department of Health

ORCID: 0000-0002-1623-2127

Observed ORCID: 0000-0002-1623-2127

OpenAlex ID: A5092394913

A Research Agenda to Inform Cannabis Regulation: How Science Can Shape Policy

2023 · Gillian L. Schauer, Julie K. Johnson, et al. · Clinical Therapeutics · 18

Pilot Randomized Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Newly Diagnosed Advanced Pancreatic Cancer (CanPan)

2026 · Dylan Zylla, Ella Chrenka, et al. · JCO Oncology Practice · 3

Benefits of Medical Cannabis in Patients With Pain Registered in the Minnesota Medical Cannabis Program

2026 · Grace M. Christensen, Susan J. Park, et al. · Clinical Therapeutics · 2

Dose response relationship of medical cannabis and symptom control in patients with pancreatic cancer: an analysis of the CANPAN trial

2026 · Arjun Gupta, Kendall Lin, et al. · The Oncologist

A randomized phase II trial of medical cannabis to reduce symptom burden in patients with newly diagnosed advanced pancreatic cancer (CanPan).

2026 · Dylan M. Zylla, Ella Chrenka, et al. · Journal of Clinical Oncology

A randomized phase II trial of medical cannabis to reduce symptom burden in patients with newly diagnosed advanced colorectal cancer (CANCOL).

2026 · Kendall Lin, Ella Chrenka, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 23

H-index: 2

I10-index: 1